CFIN researcher, Associate professor Jakob Blicher and collegues has just published a new article on: "Short echo-time Magnetic Resonance Spectroscopy in ALS, simultaneous quantifcation of glutamate and GABA at 3T" in Scientific Reports.
26.11.2019 |
J. U. Blicher1,2
S. F. Eskildsen1
T.G. Stærmose1
A. T. Møller2
K. Figlewski2
J. Near3
Cortical hyperexcitability has been found in early Amyotrophic Lateral Sclerosis (ALS) and is hypothesized to be a key factor in pathogenesis. The current pilot study aimed to investigate cortical inhibitory/excitatory balance in ALS using short-echo Magnetic Resonance Spectroscopy (MRS). Patients sufering from ALS were scanned on a 3T Trio Siemens MR scanner using Spin Echo Full Intensity Acquired Localized (SPECIAL) Magnetic Resonance Spectroscopy in primary motor cortex and the occipital lobe. Data was compared to a group of healthy subjects. Nine patients completed the scan. MRS data was of an excellent quality allowing for quantifcation of a range of metabolites of interest in ALS. In motor cortex, patients had Glutamate/GABA and GABA/Cr- ratios comparable to healthy subjects. However, Glutamate/Cr (p=0.002) and the neuronal marker N-acetyl-aspartate (NAA/Cr) (p=0.034) were low, possibly due to grey-matter atrophy, whereas Glutathione/Cr (p=0.04) was elevated. In patients, NAA levels correlated signifcantly with both hand strength (p=0.027) and disease severity (p=0.016). In summary SPECIAL MRS at 3T allows of reliable quantifcation of a range of metabolites of interest in ALS, including both excitatory and inhibitory neurotransmitters. The method is a promising new technique as a biomarker for future studies on ALS pathophysiology and monitoring of disease progression.
Link to article in Scientific Reports online ...